Association of Pre-Surgery to Pre-Radiotherapy Lymphocyte Counts Ratio With Disease-Free Survival in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy

World Journal of Surgical Oncology - United Kingdom
doi 10.1186/s12957-019-1747-9
Full Text
Abstract

Available in full text

Categories
SurgeryOncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Patterns of Failure in Patients With Locally Advanced Rectal Cancer Receiving Pre-Operative or Post-Operative Chemoradiotherapy

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2013English

Neoadjuvant Chemoradiotherapy in Combined Treatment of Patients With Rectal Cancer

Grekov's Bulletin of Surgery
2017English

Neoadjuvant Chemoradiotherapy in Rectal Cancer

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

Pre-Treatment Neutrophil to Lymphocyte Ratio Predicts the Chemoradiotherapy Outcome and Survival in Patients With Oral Squamous Cell Carcinoma: A Retrospective Study

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer in Elderly Patients: Toxicity, Disease Control, and Survival Outcomes

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Long‑term Survival Without Surgery Following a Complete Response to Pre‑operative Chemoradiotherapy for Rectal Cancer: A Case Series

Oncology Letters
Cancer ResearchOncology
2013English

Pre-Treatment Serum Inflammatory Cytokines as Survival Predictors of Patients With Nasopharyngeal Carcinoma Receiving Chemoradiotherapy

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer: Does Time to Surgery Matter?

International Surgery
Surgery
2015English

Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Predict Tumor Response and Disease-Free Survival in Locally Advanced Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy and Radical Surgery

Journal of Cancer
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy